UK-based medical equipment manufacturer Smith & Nephew has announced this week an acquisition in the field of robotic surgery.
The future of organ donation has been changed forever thanks to a new device, aptly named 'Heart in a Box', that allows a heart from a deceased person to resume beating.
Design team leader at Owen Mumford, Myles Whiting lifts the curtain and provides an exclusive backstage view of how the R&D department within a successful medical device manufacturer works.
Lucideon’s healthcare division has announced it is developing new glass-based technology which has the potential to transform dental care globally.
The United Nations General Assembly last week formally adopted the Sustainable Development Goals (SDGs), a 17-point plan to eradicate global poverty, which also formally recognised the negative impact of tobacco consumption on health, wealth, and development around the world.
The US drug manufacturer of a treatment used by Aids patients has decided to go back on the 5,000% cost increase for the medicine.
Spinifex Pharmaceuticals, which focuses on the development of new drugs for the treatment of chronic pain, has announced that it has agreed to the sale of Spinifex to Novartis International AG for an upfront cash consideration of US$200m, plus undisclosed clinical development and regulatory milestone payments.
Lorati, a Taiwan-based biotechnology and skincare company, today announced that it has successfully developed nano-medication, which can effectively inhibit HIV-1 viral replication.
Researchers from Bristol University in the UK have announced plans to begin testing artificial blood.
A new type of treatment, which could double the chances of survival for some patients suffering from the most common type of lung cancer, has been given Breakthrough Therapy Designation by the FDA.